Clinical Research Directory
Browse clinical research sites, groups, and studies.
Antagonism of Neostigmine in Continuous Infusion of Mivacurium
Sponsor: Beijing Tongren Hospital
Summary
In this study, the antagonism of neostigmine, a cholinesterase inhibitor, on continuous infusion of mivacurium during foot and ankle surgery under general anesthesia was investigated, and the appropriate time point of antagonism was explored.
Official title: Antagonism of Neostigmine in Continuous Infusion of Mivacurium: a Randomised Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-05-01
Completion Date
2026-07-29
Last Updated
2026-04-13
Healthy Volunteers
No
Conditions
Interventions
Neostigmine
Administer neostigmine at a dose of 0.04 mg/kg (combined with 0.02 mg/kg atropine)
Locations (1)
Beijing tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, China